Genesis CancerCare NSW is committed to the participation and coordination of clinical trials within its practices.
Geneiss CancerCare and Trans-Tasman Radiation Oncology Group Strategic Partnership
The Trans-Tasman Radiation Oncology Group (TROG) is a global leader in radiotherapy research working with over nine hundred researchers and doctors in more than 50 trials involving over 12,000 patient volunteers to help advance cancer treatments. GenesisCare is the leading provider of radiation oncology in Australia undertaking around 320,000 cancer treatments every year and is currently involved in over 40 clinical trials. GenesisCare and TROG will work together to improve patient access to clinical trials and promote innovation in research to deliver better patient outcomes.
The table below details the clinical trials currently recruiting, in the follow up phase and completed. Please click the provided link to go to the public trial register which provides even further information on each of the respective trials.
If you are interested in being involved with any of the active (recruiting) trials please discuss with one of our Radiation Oncologists.